German Life Sciences Stock News

LEG Immobilien (XTRA:LEG) has drawn fresh attention after reporting full year 2025 earnings and confirming an annual dividend of €2.92 per share, with payment scheduled for June 1, 2026. See our latest analysis for LEG Immobilien. LEG Immobilien’s share price has held at €65.35 after the earnings and dividend announcements, with a 30 day share price return of 5.74% and a 90 day gain of 6.09%. The 3 year total shareholder return of 20.73% contrasts with a 5 year total shareholder return...

Earnings and dividend move keep Deutsche Post (XTRA:DHL) in focus Deutsche Post (XTRA:DHL) has attracted attention after reporting full year 2025 results, a higher annual dividend, and progress on its Fit for Growth cost program supported by AI and digitalization. See our latest analysis for Deutsche Post. Despite the fresh earnings and dividend news, Deutsche Post’s share price has had a softer patch recently, with a 7.10% 1 month share price return and a 5.14% 7 day share price return. Even...

Hapag-Lloyd (XTRA:HLAG) is back in focus after a series of boardroom changes, with long-serving chairman Michael Behrendt stepping back due to illness and Karl Gernandt taking over the supervisory board leadership. See our latest analysis for Hapag-Lloyd. The governance reshuffle comes as the stock trades at €140.5, with a 30 day share price return of 17.28% and a 1 year total shareholder return of 2.32%. The 3 year total shareholder return of 31.80% and 5 year total shareholder return of...

Why Redcare Pharmacy’s latest earnings moved the stock Redcare Pharmacy (XTRA:RDC) shares reacted sharply after the company reported full year 2025 earnings, with higher sales of €2.94b, a narrower net loss of €37.7m, and fresh guidance for 2026. The market response, including a 21.01% one day drop in the share price, reflected investor focus on margin pressures, mixed cash flow signals, and how the new growth targets might affect profitability. See our latest analysis for Redcare...

Why Ströer SE KGaA (XTRA:SAX) is in focus after Q4 earnings Ströer SE KGaA (XTRA:SAX) has come into focus after reporting fourth quarter 2025 results, with sales of €603.3 million versus €586 million a year earlier, while net income slipped slightly to €65 million from €66 million. See our latest analysis for Ströer SE KGaA. The mixed Q4 result lands after a tough stretch for shareholders, with the latest 1-day share price return of 2.58% offering a brief bounce against a 1-year total...

Molecular Partners AG recently announced it has entered into an agreement with Eckert & Ziegler to support development and manufacturing of Radio-DARPin therapeutics, adding Actinium-225 to existing Lead-212–based programs for targeted cancer treatment. This collaboration broadens Eckert & Ziegler’s isotope platform into advanced Radio-DARPin applications, potentially deepening its role in supplying components for next-generation radiopharmaceuticals. We’ll now examine how partnering with...

Sixt SE recently reported full-year 2025 results, with sales rising to €4,282.98 million and net income to €285.81 million, alongside the launch of its SIXT ONE rewards program in the U.S. and select European markets. An interesting angle for investors is how SIXT ONE, designed around status-driven benefits and loyalty, supports Sixt’s broader international expansion focus, especially in the key U.S. market. We’ll now explore how these record 2025 results and the rollout of SIXT ONE shape...

Frasers Group, controlled by Mike Ashley, has acquired a substantial stake in Puma, listed as XTRA:PUM. The purchase makes Frasers Group the second largest shareholder in the German sportswear company. This change in the shareholder base adds a new, high profile investor with a track record in retail and sports brands. Puma, traded as XTRA:PUM, is a global sportswear and footwear company that competes with major athletic brands for performance and lifestyle consumers. The sector continues...

RENK Group (XTRA:R3NK) is back in focus after reporting record revenue and order intake, issuing 2026 guidance for revenue above €1.5b and proposing a 38% higher dividend of €0.58 per share. See our latest analysis for RENK Group. The latest earnings beat, 2026 revenue guidance above €1.5b and the proposed higher dividend have coincided with a 7.13% 1 day share price return. However, year to date share price performance is almost flat, while the 1 year total shareholder return of 57.70%...

In recent updates, ATOSS Software AG, a German workforce management specialist, reported continued strong performance underpinned by its recurring software fees and cloud subscription model, reinforcing its profile as a profitable, high-margin SaaS provider. An interesting angle for investors is ATOSS’s exposure to complex European labor markets, where stringent workforce regulations can underpin demand for its scheduling and compliance tools while offering diversification outside more...

flatexDEGIRO (XTRA:FTK) is back in focus after reporting fourth quarter and full year 2025 results, with higher revenue, higher net income and a larger customer base drawing fresh attention from investors. See our latest analysis for flatexDEGIRO. At a share price of €32.24, flatexDEGIRO has a 1-day share price return of 0.94% and a 7-day share price return of 4.61%. This sits against a weaker recent patch that includes a 30-day share price return of 17.67% and a year to date share price...

Vantage Towers (HMSE:VTWR) just announced a collaboration with Gridle, Elisa Industriq's energy optimization business, to apply AI driven battery management across its Spanish tower network and to support a future virtual power plant model. See our latest analysis for Vantage Towers. The Gridle partnership lands at a time when Vantage Towers' momentum is fairly steady, with a 90 day share price return of 2.69% and a 1 year total shareholder return of 6.16% at a share price of €38.2. This...

If you are wondering whether Dr. Ing. h.c. F. Porsche is attractively priced today, it helps to step back and separate the recent share price swings from the underlying value. The stock last closed at €37.85, with returns of an 8.6% decline over 7 days, a 4.6% decline over 30 days, a 20.5% decline year to date, and a 27.7% decline over the past year, while the 3-year return stands at a 63.6% decline. These moves have put the company firmly on many investors' watchlists, prompting fresh...

Deutsche Post (XTRA:DHL) kept freight moving through the Middle East by rerouting cargo and adjusting operations during the ongoing conflict. The group maintained service in affected trade lanes despite severe supply chain disruptions in the region. Its Fit for Growth program reached cost saving targets ahead of schedule, using AI and digital tools to streamline processes. These developments highlight how the company is handling operational risk and efficiency efforts at the same time. For...

If you are wondering whether Deutsche Lufthansa is attractively priced right now or if the recent share level reflects fair value, you are not alone. The stock last closed at €8.12, with returns of a 10.7% decline over 7 days and a 10.3% decline over 30 days, while the 1 year return stands at 6.6% and the 5 year return at 4.7%. Recent headlines have focused on Deutsche Lufthansa's ongoing efforts to manage its network, cost base and balance sheet. This helps frame how the market is...

Heidelberg Materials has decided to close its Paderborn cement plant in Germany. The closure follows weak construction demand that has put pressure on cement volumes in the region. The move reflects a broader effort to adjust the company’s production footprint to current market conditions. For investors watching XTRA:HEI, the closure comes after a volatile period for the share price, with the stock at €174.1 and showing a 21.5% decline year to date and an 18.5% decline over the past month...

If you are wondering whether adidas shares are starting to look interesting or still too expensive, you are not alone. Many investors are asking what the current price really reflects about the business. The stock closed at €141.80, with a 10.5% decline over 7 days, a 5.6% decline over 30 days, a 15.3% decline year to date, a 39.9% decline over 1 year and a 48.9% decline over 5 years. This naturally raises questions about how expectations and risk are being priced in. Recent coverage around...

Fresenius SE KGaA (XTRA:FRE) is back in focus after reporting fourth quarter 2025 results, proposing a €1.05 dividend per share and outlining board changes alongside management’s comments on geopolitical and supply chain pressures. See our latest analysis for Fresenius SE KGaA. Even with the earnings beat, higher proposed dividend and board changes, the share price has slipped over the past week, with a 7 day share price return of 4.27%. However, a 1 year total shareholder return of 25.23%...

BASF (XTRA:BAS) has been highlighted as a key player in the ammonium sulfate market. A recent industry report points to projected growth in ammonium sulfate demand across fertilizers, food processing, and emissions control. The company is positioned among top global suppliers, which may create additional opportunities for business expansion. BASF is a global chemicals group with exposure to agricultural inputs and industrial applications where ammonium sulfate plays an important role. The...

Wondering whether SAP at €165.48 is starting to look attractive or still expensive compared to its fundamentals? This article is designed to help you put a clear value range around the stock. The share price has had a mixed run, with a 0.2% decline over the last 7 days and a 3.0% decline over 30 days, while year to date it is down 18.1% and 35.5% lower over 1 year. It is still up 55.2% over 3 years and 69.5% over 5 years. Recent headlines around SAP have focused on broader sector sentiment,...

Why Fresenius Medical Care is back on investors’ radar Fresenius Medical Care (XTRA:FME) has just packed several key updates into its 2025 results, including a sharp rise in net income, higher earnings per share, new 2026 guidance, a higher proposed dividend, and completion of a sizeable buyback. See our latest analysis for Fresenius Medical Care. These 2025 results, new 2026 guidance and the completed buyback come after a mixed stretch for the stock, with a 30 day share price return of 4.22%...

Bank of America Corporation has disclosed that its total voting rights in Mercedes-Benz Group AG have risen above the 5% threshold. The crossing of this regulatory threshold was reported under European securities rules and marks a material change in a major financial institution’s position. For you as an investor looking at XTRA:MBG, this stake change comes against a mixed share price record. The stock is at €55.76, with a 1 year return of 4.8% and a 5 year return of 28.9%, while the year...

If you are wondering whether Münchener Rückversicherungs-Gesellschaft in München is offering fair value at current levels, starting with a clear view of its valuation can help you frame your next move. The share price recently closed at €551.80, with returns of 1.7% over the last 7 days, 7.7% over the last 30 days, 2.1% year to date, 1.6% over 1 year, 85.0% over 3 years and 151.7% over 5 years. This gives useful context before comparing price to fundamentals. Recent news around large...

Hensoldt AG recently reported its 2025 results, with sales rising to €2,455 million from €2,240 million, while net income eased to €89 million from €108 million. Alongside extending CEO Oliver Dörre’s contract to 2031, Hensoldt booked a record €4.71 billion order intake for 2025 and raised its 2026 guidance, underscoring strong demand for its defense sensor technologies. Next, we’ll examine how this record order intake and raised 2026 guidance may reshape Hensoldt’s investment narrative and...